Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology
PR Newswire Asia
SEONGNAM, South Korea and AURORA, Colo., March 27, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a South Korean..